Rua Life Sciences PLC
LSE:RUA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Rua Life Sciences PLC
Total Receivables
Rua Life Sciences PLC
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Rua Life Sciences PLC
LSE:RUA
|
Total Receivables
£957k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Total Receivables
£2.7m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Total Receivables
$439m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Total Receivables
£8.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Inspecs Group PLC
LSE:SPEC
|
Total Receivables
£36.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Total Receivables
£50.1m
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Rua Life Sciences PLC
Glance View
RUA Life Sciences Plc is a holding company, which engages in the commercialization of biomedical polymer technology, components, and medical devices. The company is headquartered in Ayrshire, Ayrshire and currently employs 32 full-time employees. The firm is a manufacturer of medical devices and licensor of its IP and know-how together with developing medical devices utilizing its polymer IP. The firm operates through four businesses. Its RUA Medical business provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class seven and eight cleanroom suites. Its RUA Biomaterials is the depository of the IP and licensing rights to a range of biostable, implantable polymers, including Elast-EonTM and ECSilTM. Its RUA Vascular business is the legal manufacturer and IP holder of the Company’s cardiovascular and soft tissue patches and bore vascular grafts. Its RUA Structural Heart business holds the intellectual property relating to the Company’s synthetic heart valve technology.
See Also
What is Rua Life Sciences PLC's Total Receivables?
Total Receivables
957k
GBP
Based on the financial report for Sep 30, 2025, Rua Life Sciences PLC's Total Receivables amounts to 957k GBP.